5 Best 52-Week High Stocks To Buy Now

3. IVERIC bio, Inc. (NASDAQ:ISEE)

Number of Hedge Fund Holders: 51

IVERIC bio, Inc. (NASDAQ:ISEE) is a Cranbury, New Jersey-based biotech company founded in 2007.

The company is working on developing therapeutics for patients suffering from retinal dystrophy and degeneration. Experts consider this as a complex disease segment in which IVERIC bio, Inc. (NASDAQ:ISEE) is trying to make headway through its Zimura label that stops the creation of new blood vessels in the retina and treats geographic atrophy (GA). This ailment is primarily associated with advanced age-related macular degeneration (AMD). The drug is administrated directly into the eye through an intravitreal injection monthly, and patients start to see an improvement in vision in four to six weeks. Experts think the pharmaceutical industry’s AMD business is a flourishing segment. Although the industry is still young, it is anticipated to grow at a strong CAGR of 8.2% from 2018 to 2024, benefiting a company like IVERIC bio, Inc. (NASDAQ:ISEE).

Follow Iveric Bio Inc. (NASDAQ:ISEE)